Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.19 -2.46%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Protalix BioTherapeutics Accounts Receivables 2011-2024 | PLX

Annual Accounts Receivables Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.27 M 4.59 M 3.44 M 2 M 4.7 M 4.73 M 1.72 M 693 K - 1.88 M 2.09 M 1.41 M 1.37 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.27 M 693 K 2.83 M

Quarterly Accounts Receivables Protalix BioTherapeutics

2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
10.1 M 8.94 M 4.05 M 1.3 M 4.59 M 8.65 M 2.02 M 5.91 M 3.44 M 5.56 M 2.33 M 4.6 M 2 M 2 M 2 M 2 M 4.7 M 4.7 M 4.7 M 4.7 M 4.73 M 4.73 M 4.73 M 4.73 M 1.72 M 1.72 M 1.72 M 1.72 M 693 K 693 K 693 K 693 K - 4.57 M - 1.82 M 1.88 M 1.99 M 1.88 M 1.88 M 2.09 M 2.09 M 2.09 M 2.09 M 1.41 M 1.41 M 1.41 M 1.41 M 1.37 M 1.37 M 1.37 M 1.37 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
10.1 M 693 K 3.01 M